{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:41:57Z","timestamp":1790235717393,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijcard.2017.03.155","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T15:01:15Z","timestamp":1491058875000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016"],"prefix":"10.1016","volume":"238","author":[{"given":"Masakazu","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.155_bb0005","first-page":"246-60","article-title":"Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure. Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure","volume":"7","author":"Loncar","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0010","doi-asserted-by":"crossref","first-page":"424-33","DOI":"10.1002\/ejhf.240","article-title":"Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials","volume":"17","author":"Rossignol","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0020","doi-asserted-by":"crossref","first-page":"253-9","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0025","doi-asserted-by":"crossref","first-page":"1283-93","DOI":"10.1002\/ejhf.400","article-title":"Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"17","author":"Steinbeck","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0030","doi-asserted-by":"crossref","first-page":"367-77","DOI":"10.1017\/S0029665115002438","article-title":"The wasting continuum in heart failure: from sarcopenia to cachexia","volume":"74","author":"von Haehling","year":"2015","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13539-012-0089-z","article-title":"From muscle wasting to sarcopenia and myopenia: update 2012","volume":"3","author":"von Haehling","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0040","doi-asserted-by":"crossref","first-page":"1758-64","DOI":"10.1016\/S0735-1097(97)00381-1","article-title":"Skeletal muscle function and its relation to exercise tolerance in chronic heart failure","volume":"30","author":"Harrington","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ehf2.12035","article-title":"Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure","volume":"2","author":"Doehner","year":"2015","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.81.2.518","article-title":"Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure","volume":"81","author":"Sullivan","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0055","doi-asserted-by":"crossref","first-page":"B117","DOI":"10.1093\/gerona\/51A.2.B117","article-title":"Complexity of age related change in skeletal muscle","volume":"51A","author":"Brown","year":"1996","journal-title":"J. Gerontol. Biol. Sci."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: an update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcsm.12011","article-title":"The delayed recovery of the remobilized rat tibialis anterior muscle reflects a defect in proliferative and terminal differentiation that impairs early regenerative processes","volume":"6","author":"Slimani","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0070","doi-asserted-by":"crossref","first-page":"275-83","DOI":"10.1002\/jcsm.12065","article-title":"Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults","volume":"7","author":"Foong","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0075","doi-asserted-by":"crossref","first-page":"325-34","DOI":"10.1002\/jcsm.12026","article-title":"Higher serum phosphorus is associated with catabolic\/anabolic imbalance in heart failure","volume":"6","author":"Rozentryt","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030276","article-title":"Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy","volume":"7","author":"Rezk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcsm.12006","article-title":"Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines","volume":"6","author":"Matsuo","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.114.305393","article-title":"Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression","volume":"117","author":"Bois","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","article-title":"P, Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I","volume":"142","author":"Brink","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0105","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.cellsig.2007.04.003","article-title":"Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II","volume":"19","author":"Russell","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0110","doi-asserted-by":"crossref","first-page":"239-46","DOI":"10.1007\/s13539-014-0133-2","article-title":"1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model","volume":"5","author":"Cichello","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-012-0062-x","article-title":"Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia","volume":"3","author":"Pedroso","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0120","doi-asserted-by":"crossref","first-page":"160-6","DOI":"10.1016\/j.ijcard.2013.10.022","article-title":"Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia","volume":"170","author":"Elkina","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0125","doi-asserted-by":"crossref","unstructured":"T. Sente, AM. Van Berendoncks, VY. Hoymans, CJ. Vrints, Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure, J. Cachex. Sarcopenia Muscle 7 (2016) 261-74.","DOI":"10.1002\/jcsm.12086"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview","volume":"2","author":"Elkina","year":"2011","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MCO.0b013e32833862df","article-title":"Signaling pathways perturbing muscle mass","volume":"13","author":"Glass","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0145","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.onc.1207390","article-title":"Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases","volume":"23","author":"Marmor","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0150","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.2538923","article-title":"A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein","volume":"243","author":"Chau","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0155","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1113\/jphysiol.2006.118042","article-title":"Alterations in mRNA expression and protein products following spinal cord injury in humans","volume":"579","author":"Urso","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0165","doi-asserted-by":"crossref","first-page":"165-80","DOI":"10.1002\/jcsm.12057","article-title":"Muscle RING-finger 2 and 3 maintain striated-muscle structure and function","volume":"7","author":"Lodka","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmb.2005.09.068","article-title":"Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin","volume":"354","author":"Kudryashova","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2044-5040-3-11","article-title":"Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells","volume":"3","author":"An","year":"2013","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0180","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1083\/jcb.201006098","article-title":"Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice","volume":"191","author":"Paul","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0185","doi-asserted-by":"crossref","first-page":"381-90","DOI":"10.1002\/jcsm.12034","article-title":"Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm","volume":"6","author":"Mangner","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0190","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0195","doi-asserted-by":"crossref","first-page":"181-91","DOI":"10.1002\/jcsm.12019","article-title":"Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat","volume":"6","author":"Kob","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.01-0866com","article-title":"Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy","volume":"16","author":"Hunter","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/bjoc.2001.1879","article-title":"Activation of ATP-ubiquitin- dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)","volume":"85","author":"Lorite","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00726-003-0018-8","article-title":"Peroxynitrite reactivity with amino acids and proteins","volume":"25","author":"Alvarez","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0225","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/emboj.2010.60","article-title":"Mitochondrial fission and remodeling contributes to muscle atrophy","volume":"29","author":"Romanello","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0235","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0240","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/MCB.01347-08","article-title":"Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading","volume":"29","author":"Nakao","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.devcel.2011.09.011","article-title":"The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling","volume":"21","author":"Shi","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2011.09.079","article-title":"Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure","volume":"162","author":"Loncar","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0260","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","article-title":"Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure","volume":"20","author":"Anker","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0270","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/157340308784245757","article-title":"Chronic heart failure and exercise intolerance: the hemodynamic paradox","volume":"4","author":"Nilsson","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0280","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","article-title":"Alteration of skeletal muscle in chronic heart failure","volume":"85","author":"Drexler","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/h93-029","article-title":"Effects of ageing on the motor unit: a brief review","volume":"18","author":"Doherty","year":"1993","journal-title":"Can. J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/02841860802130001","article-title":"Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia","volume":"48","author":"Weber","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1871530311313010008","article-title":"Sarcopenia, cachexia and congestive heart failure in the elderly","volume":"13","author":"Zamboni","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0305","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcsm.12105","article-title":"Skeletal muscle satellite cells are located at a closer proximity to capillaries in healthy young compared with older men","volume":"7","author":"Nederveen","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2000","key":"10.1016\/j.ijcard.2017.03.155_bb0310","first-page":"1321-6","article-title":"Aging of skeletal muscle: a 12-yr longitudinal study","volume":"88","author":"Frontera","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1013122805060","article-title":"Age and sex influence on oxidative damage and functional status in human skeletal muscle","volume":"22","author":"Fan\u00f2","year":"2001","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0320","doi-asserted-by":"crossref","first-page":"R337","DOI":"10.1152\/ajpregu.00469.2004","article-title":"Mechanisms of disuse muscle atrophy: role of oxidative stress","volume":"288","author":"Powers","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0325","doi-asserted-by":"crossref","first-page":"929-41","DOI":"10.1002\/ejhf.156","article-title":"Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC","volume":"16","author":"Corr\u00e0","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0330","doi-asserted-by":"crossref","first-page":"180-8","DOI":"10.1111\/ejhf.37","article-title":"Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study","volume":"16","author":"Khan","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0335","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ejhf.534","article-title":"MECKI score research group, exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI score research group","volume":"18","author":"Piepoli","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0340","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0345","doi-asserted-by":"crossref","first-page":"482-9","DOI":"10.1002\/ejhf.516","article-title":"Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency","volume":"18","author":"Anker","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"Suppl","key":"10.1016\/j.ijcard.2017.03.155_bb0350","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1164\/arrd.1984.129.2P2.S60","article-title":"Exercise testing in the evaluation of the patient with chronic cardiac failure","volume":"129","author":"Weber","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9149(81)90286-1","article-title":"Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure","volume":"47","author":"Franciosa","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0360","doi-asserted-by":"crossref","first-page":"1240-51","DOI":"10.1002\/ejhf.403","article-title":"Association of impaired left ventricular twisting-untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease","volume":"17","author":"Ikonomidis","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ehf2.12034","article-title":"Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction\u2014results from the DIAST-CHF study","volume":"2","author":"Stahrenberg","year":"2015","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ehf2.12049","article-title":"Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction","volume":"3","author":"Kasner","year":"2015","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0375","doi-asserted-by":"crossref","first-page":"287-96","DOI":"10.1007\/s13539-014-0152-z","article-title":"Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones","volume":"5","author":"Josiak","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0380","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-014-0132-3","article-title":"From sarcopenia to frailty: a road less traveled","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0385","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcsm.12051","article-title":"SPRINTT consortium, biomarkers for physical frailty and sarcopenia: state of the science and future developments","volume":"6","author":"Calvani","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ehf2.12052","article-title":"Frailty may be a risk marker for adverse outcome in patients with congestive heart failure","volume":"2","author":"Yamada","year":"2015","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0395","doi-asserted-by":"crossref","first-page":"869-75","DOI":"10.1002\/ejhf.518","article-title":"Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure","volume":"18","author":"Vid\u00e1n","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0400","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1136\/hrt.72.2_Suppl.S36","article-title":"Symptoms and quality of life in heart failure: the muscle hypothesis","volume":"72","author":"Coats","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1152\/jappl.1997.82.1.257","article-title":"Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure","volume":"82","author":"Lang","year":"1997","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0410","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.85.4.1364","article-title":"Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure","volume":"85","author":"Mancini","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0415","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/jappl.1993.75.1.373","article-title":"Skeletal muscle size: relationship to muscle function in heart failure","volume":"75","author":"Minotti","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0420","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/S0735-1097(01)01306-7","article-title":"Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure","volume":"37","author":"Cicoira","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0430","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacc.2012.02.055","article-title":"Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction","volume":"60","author":"Haykowsky","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0435","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Heart Failure Association of the ESC, are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0440","doi-asserted-by":"crossref","first-page":"678-84","DOI":"10.1002\/ejhf.81","article-title":"Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study","volume":"16","author":"B\u00f8lling","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0445","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0450","doi-asserted-by":"crossref","first-page":"442-52","DOI":"10.1002\/ejhf.252","article-title":"Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodeling","volume":"17","author":"G\u00fcder","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0455","doi-asserted-by":"crossref","first-page":"907-14","DOI":"10.1002\/ejhf.121","article-title":"Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial","volume":"16","author":"D\u00fcngen","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0460","doi-asserted-by":"crossref","first-page":"514-22","DOI":"10.1002\/ejhf.510","article-title":"QUALIFY investigator, physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0465","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcard.2017.03.155_bb0470","doi-asserted-by":"crossref","first-page":"319-22","DOI":"10.1016\/j.ijcard.2005.01.061","article-title":"Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study","volume":"106","author":"Lainscak","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2012.10.018","article-title":"Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology","volume":"162","author":"Anker","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0480","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcsm.12082","article-title":"Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment","volume":"6","author":"Drescher","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0485","doi-asserted-by":"crossref","first-page":"149-58","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0490","doi-asserted-by":"crossref","first-page":"400-2","DOI":"10.1002\/jcsm.12136","article-title":"ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker","volume":"7","author":"Lainscak","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0495","doi-asserted-by":"crossref","first-page":"355-65","DOI":"10.1002\/jcsm.12126","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12191","article-title":"Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial","author":"Clark","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0505","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.025","article-title":"Muscle wasting in heart failure: an overview","volume":"45","author":"von Haehling","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0510","doi-asserted-by":"crossref","first-page":"269-77","DOI":"10.1007\/s13539-014-0162-x","article-title":"Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management","volume":"5","author":"Wakabayashi","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/SPC.0000000000000030","article-title":"Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview","volume":"8","author":"Ebner","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0520","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.phrs.2015.05.010","article-title":"Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action","volume":"99","author":"Dutt","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0525","doi-asserted-by":"crossref","first-page":"279-86","DOI":"10.1007\/s13539-014-0154-x","article-title":"Cachexia: a problem of energetic inefficiency","volume":"5","author":"Argil\u00e9s","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0530","doi-asserted-by":"crossref","first-page":"269-71","DOI":"10.1002\/jcsm.12088","article-title":"Cachexia: a nutritional syndrome?","volume":"6","author":"Anker","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0535","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jcsm.12032","article-title":"Conversion of leucine to \u03b2-hydroxy-\u03b2-methylbutyrate by \u03b1-keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes","volume":"7","author":"Gir\u00f3n","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0540","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jcsm.12100","article-title":"Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals","volume":"7","author":"Toneto","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0545","doi-asserted-by":"crossref","first-page":"193-8","DOI":"10.1007\/s13539-014-0157-7","article-title":"Muscle wasting: an overview of recent developments in basic research","volume":"5","author":"Palus","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13539-014-0136-z","article-title":"Highlights from the 7th cachexia conference: muscle wasting pathophysiological detection and novel treatment strategies","volume":"5","author":"Ebner","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0555","doi-asserted-by":"crossref","first-page":"125-36","DOI":"10.1007\/s13539-012-0098-y","article-title":"Sources for skeletal muscle repair: from satellite cells to reprogramming","volume":"4","author":"Sirabella","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0560","doi-asserted-by":"crossref","first-page":"803-69","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0565","doi-asserted-by":"crossref","first-page":"631-8","DOI":"10.1002\/ejhf.271","article-title":"Committee on Exercise Physiology & Training of the Heart Failure Association of the ESC, ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients","volume":"17","author":"Piepoli","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0570","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.047381","article-title":"Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig exercise intervention in chronic heart failure and aging catabolism study","volume":"125","author":"Gielen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0575","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041701","article-title":"Exercise training prevents oxidative stress and ubiquitin\u2013proteasome system overactivity and reverse skeletal muscle atrophy in heart failure","volume":"7","author":"Cunha","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1751-7133.2011.00217.x","article-title":"The effect of physical training on systemic proinflammatory cytokine expression in heart failure patients: a systematic review","volume":"17","author":"Smart","year":"2011","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0590","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13539-012-0067-5","article-title":"Are there any benefits of exercise training in cancer cachexia?","volume":"3","author":"Argiles","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0595","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drug to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0600","doi-asserted-by":"crossref","first-page":"208-11","DOI":"10.1002\/jcsm.12055","article-title":"Exercise for cancer cachexia in adults: executive summary of a Cochrane collaboration systematic review","volume":"6","author":"Grande","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0605","doi-asserted-by":"crossref","first-page":"574-82","DOI":"10.1002\/ejhf.70","article-title":"Combined aerobic\/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: the Vent-HeFT trial: a European prospective multicentre randomized trial","volume":"16","author":"Adamopoulos","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0610","doi-asserted-by":"crossref","first-page":"312-21","DOI":"10.1002\/jcsm.12076","article-title":"Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study","volume":"7","author":"Tyrovolas","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0615","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13539-012-0090-6","article-title":"Research on cachexia, sarcopenia and skeletal muscle in cardiology","volume":"3","author":"Coats","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0620","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: molecular mechanisms","volume":"4","author":"Gould","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2013.05.015","article-title":"Exercise for falls and fracture prevention in long term care facilities: a systematic review and meta-analysis","volume":"14","author":"Silva","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0635","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.hjr.0000173106.68485.b7","article-title":"Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure","volume":"12","author":"Hambrecht","year":"2005","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0640","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1152\/japplphysiol.00545.2010","article-title":"Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function","volume":"110","author":"Toth","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0645","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1073\/pnas.0911570106","article-title":"Increased muscle PGC-1a expression protects from sarcopenia and metabolic disease during aging","volume":"106","author":"Wenz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0650","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrrheum.2014.193","article-title":"Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation","volume":"11","author":"Benatti","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0655","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.jrn.2010.10.012","article-title":"Exercise as an anabolic intervention in patients with end-stage renal disease","volume":"21","author":"Ikizler","year":"2011","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0660","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","article-title":"Effect of physical exercise on muscle mass and strength in cancer patients during treatment-a systematic review","volume":"88","author":"Stene","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0665","doi-asserted-by":"crossref","first-page":"263-72","DOI":"10.1002\/ejhf.239","article-title":"Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle","volume":"17","author":"Bowen","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"2005","key":"10.1016\/j.ijcard.2017.03.155_bb0670","first-page":"1154","article-title":"The anti-inflammatory effect of exercise","volume":"98","author":"Petersen","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0675","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0735-1097(03)00848-9","article-title":"Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure","volume":"42","author":"Gielen","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0680","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2004.06.129","article-title":"Exercise normalises overexpression of TNF-alpha in knockout mice","volume":"321","author":"Keller","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0685","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1677\/joe.1.06779","article-title":"Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-resenting cells in aging type-2 diabetic men with partial androgen deficiency","volume":"189","author":"Corrales","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0690","doi-asserted-by":"crossref","first-page":"2060-7","DOI":"10.4049\/jimmunol.167.4.2060","article-title":"Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production","volume":"167","author":"Liva","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0695","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2014.02.004","article-title":"Lifelong training preserves some redox-regulated adaptive responses after an acute exercise stimulus in aged human skeletal muscle","volume":"70","author":"Cobley","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0700","doi-asserted-by":"crossref","first-page":"626-34","DOI":"10.1007\/s12020-012-9836-3","article-title":"Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status","volume":"43","author":"Christensen","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","article-title":"Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct","volume":"180","author":"Sharma","year":"1990","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0710","doi-asserted-by":"crossref","first-page":"342-8","DOI":"10.1093\/eurjhf\/hfp020","article-title":"Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model","volume":"11","author":"Lenk","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0715","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SPC.0b013e3283196ac2","article-title":"Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia","volume":"2","author":"Attaix","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0720","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ehf2.12033","article-title":"Muscle wasting in ageing and chronic illness","volume":"2","author":"Ebner","year":"2015","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0725","doi-asserted-by":"crossref","first-page":"110-25","DOI":"10.1002\/jcsm.12058","article-title":"Diet composition as a source of variation in experimental animal models of cancer cachexia","volume":"7","author":"Giles","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clnu.2015.02.004","article-title":"Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation","volume":"35","author":"Pineda-Juarez","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0735","doi-asserted-by":"crossref","first-page":"1145-55","DOI":"10.1517\/17460440903300842","article-title":"Animal models of anorexia and cachexia","volume":"4","author":"Deboer","year":"2009","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ijcard.2017.03.155_bb0740","doi-asserted-by":"crossref","first-page":"227-52","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0745","doi-asserted-by":"crossref","first-page":"388-93","DOI":"10.1016\/j.ijcard.2009.01.060","article-title":"The influence of age and sex on disease development in a novel animal model of cardiac cachexia","volume":"133","author":"Palus","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0750","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2353\/ajpath.2007.060505","article-title":"Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice","volume":"170","author":"Li","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0755","doi-asserted-by":"crossref","first-page":"420-30","DOI":"10.1161\/CIRCHEARTFAILURE.109.888479","article-title":"Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure","volume":"3","author":"Kato","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.155_bb0760","doi-asserted-by":"crossref","first-page":"130-6","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317320661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317320661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T14:10:54Z","timestamp":1568988654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317320661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":146,"alternative-id":["S0167527317320661"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.155","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}